TUR and adjuvant intravesical chemotherapy in T1G3 bladder tumors: Recurrence, progression and survival in 137 selected patients followed up to 20 years

European Urology

Volumn 45, Issue 6, 2004, Pages 730-736

  Serretta, Vincenzo ^a   Pavone, Carlo ^a   Ingargiola, Giovan Battista ^a   Daricello, Giuseppe ^a   Allegro, Rosalinda ^a   Pavone Macaluso, Michele ^a  

^a UNIVERSITY OF PALERMO   (Italy)

Author keywords

Conservative treatment; Intravesical adjuvant chemotherapy; T1G3 bladder cancer

Indexed keywords

DOXORUBICIN; EPIRUBICIN; MITOMYCIN C;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; BLADDER CARCINOMA; CANCER RECURRENCE; CANCER SURVIVAL; CONSERVATIVE TREATMENT; CYSTECTOMY; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; RECURRENCE RISK; SURVIVAL RATE; TIME SERIES ANALYSIS; TRANSITIONAL CELL CARCINOMA; TRANSURETHRAL RESECTION; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, TRANSITIONAL CELL; CHEMOTHERAPY, ADJUVANT; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; SURVIVAL RATE; TIME FACTORS; URINARY BLADDER NEOPLASMS; UROLOGIC SURGICAL PROCEDURES;

EID: 2442619175     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2003.12.002     Document Type: Article

References (29)

1. Amling C.L., Thrasher J.B., Frazier H.A., Dodge R.K., Robertson J.E., Paulson D.F. Radical cystectomy for stages Ta, Tis and T1 transitional cell carcinoma of the bladder. J. Urol. 151:1994;31-36
2. Freeman J.A., Esrig D., Stein J.P. Radical cystectomy for high risk patients with superficial bladder cancer in the era of orthotopic urinary reconstruction. Cancer. 76:1995;833-839
3. Sylvester R.J., van der Meijden A.P.M., Lamm D.L. Intravesical bacillus Calmette-Guerin reduces the risk of progression in patients with superficial bladder cancer: a meta-analysis of the published results of randomized clinical trials. J. Urol. 168:2002;1964-1970
4. Davis J.W., Sheth S.I., Doviak M.J., Schellhammer P.F. Superficial bladder carcinoma treated with bacillus Calmette-Guerin: progression-free and disease specific survival with minimum 10-year followup. J. Urol. 167:2002;494-501
5. Oosterlinck W., Lobel B., Jakse G., Malmstrom P., Stockle M., Sternberg C. Guidelines on bladder cancer. Eur. Urol. 41:2002;105-112
6. Pagano F., Garbeglio A., Milani C., Bassi P., Pegorna A. Prognosis of bladder cancer: Risk factors in superficial transitional cell cancer. Eur. Urol. 13:1987;145-151
7. Gilbert H.A., Logan J.L., Kogan A.R., Friedman H.A., Cove J.K., Fox M., et al. The natural history of papillary transitional cell carcinoma of the bladder and its treatment in an unselected population on the basis of histological grading. J. Urol. 119:1978;488-493
8. Birch B.R.P., Harlands S.J. The pT1G3 bladder tumour. Br. J. Urol. 64:1989;109-116
9. Cookson M.S., Herr H.W., Zhang Z.F., Soloway S., Sogani P.C., Fair W.R. The treated natural history of high risk superficial bladder cancer: 15-year outcome. J. Urol. 158:1997;62-67
10. Baniel J, Grauss D, Engelstein D, Sella. Intravesical bacillus Calmette-Guerin treatment for Stage T1 grade 3 transitional cell carcinoma of the bladder. Urology 1998;52:785-9.
11. Shanin O., Thalmann G.N., Rentsch C., Mazzucchelli L., Studer U.E. A retrospective analysis of 153 patients treated with or without intravesical bacillus Calmette-Guerin fro primary stage T1 grade 3 bladder cancer: recurrence, progression and survival. J. Urol. 169:2003;96-100
12. Herr H.W. The value of a second transurethral resection in evaluating patients with bladder tumors. J. Urol. 162:1999;74-79
13. Brake M., Loertzer H., Horsch R., Keller H. Recurrence and progression of stage T1, grade 3 transitional cell carcinoma of the bladder following intravesical immunotherapy with bacillus Calmette-Guerin. J. Urol. 163:2000;1697-1701
14. Herr W.H. Tumor progression and survival of patients with high grade, noninvasive papillary (TaG3) bladder tumors: 15-year outcome. J. Urol. 163:2000;60-62
15. Dal Bo V., Belmonte P., Veronesi A., Lo Re G., Miotto E., Merlo A., et al. Intravesical BCG instillations in patients with carcinoma in situ and pT1 G3 transitional cell carcinoma of the bladder. Eur. Urol. 18(Suppl. 1):1990;43. [Abstract 82]
16. Herr H.W. Progression of stage T1 bladder tumors after intravesical bacillus Calmette-Guerin. J. Urol. 145:1991;40-44
17. Eure G.R., Cundiff M.R., Schellhammer P.F. Bacillus Calmette-Guerin therapy for high risk stage T1 superficial bladder cancer. J. Urol. 147:1992;376-379
18. Bono A.V., Benvenuti C., Damiano G., Lovisolo J. Results of transurethral resection and intravesical doxorubicin prophylaxis in patients with T1 G3 bladder cancer. Urology. 44:1994;329-335
19. Pansadoro V., Emiliozzi P., Defidio D. Bacillus Calmette-Guerin in the treatment of stage T1 grade 3 transitional cell carcinoma of the bladder: long term results. J. Urol. 154:1995;2054-2058
20. Serretta V., Piazza S., Pavone C., Piazza B., Pavone-Macaluso M. Result of conservative treatment (transurethral resection plus adjuvant intravesical chemotherapy) in patients with primary T1 G3 transitional cell carcinoma of the bladder. Urology. 47:1996;647-651
21. Gohji K., Nomi M., Okamoto M., Takenata A., Hara I., Okada H., et al. Conservative therapy for stage T1b grade 3 transitional cell carcinoma of bladder. Urology. 53:1999;308-313
22. Hurle R., Losa A., Manzetti A., Lembo A. Intravesical Bacille Calmette Guerin in stage T12 grade 3 bladder cancer therapy: a 7-year follow-up. Urology. 54:1999;258-263
23. Bono A.V., Lovisolo J.A., Saredi G. Transurethral resection and sequential chemo-immunoprophylaxis in primary T1G3 bladder cancer. Eur. Urol. 37:2000;478-483
24. Kulkarni J.N., Gupta R. Recurrence and progression in stage T1G3 bladder tumour with intravesical bacille Calmette-Guerin (Danish 1331 strain). BJU Int. 90:2002;554-557
25. Bogdanovic J., Marusic G., Djozic J., Sekulic V., Budakof P., Dejanovic N., et al. The management of T1G3 bladder cancer. Urol. Int. 69:2002;263-265
26. Sekine H, Ohya K, Kojima SI, Igarashi K, Fukui I. Equivalent efficacy of Mitomycin C plus Doxorubicin instillation to bacillus Calmette-Guerin therapy for carcinoma in situ of the bladder. Int J Urol 2001;8:483-48.
27. Pawinski A., et al. A combined analysis of European Organisation for Research and Treatment of Cancer and Medical Research Council randomised clinical trials for the prophylactic treatment of stage TaT1 bladder cancer. J. Urol. 156:1996;1934-1941
28. Sylvester R.J., et al. Intravesical bacillus Calmette-Guérin reduces the risk of progression in patients with superficial bladder cancer: a meta-analysis of the published results of randomized clinical trials. J. Urol. 168:2002;1964-1970
29. Herr W.H. Tumor progression and survival of patients with high grade, noninvasive (TaG3) bladder tumors:15 years outcome. J. Urol. 163:2000;60-62